Posts written by:

Josh Landau

Joshua Landau is the Patent Counsel at the Computer & Communications Industry Association (CCIA), where he represents and advises the association regarding patent issues. Mr. Landau joined CCIA from WilmerHale in 2017, where he represented clients in patent litigation, counseling, and prosecution, including trials in both district courts and before the PTAB.

Prior to his time at WilmerHale, Mr. Landau was a Legal Fellow on Senator Al Franken’s Judiciary staff, focusing on privacy and technology issues. Mr. Landau received his J.D. from Georgetown University Law Center and his B.S.E.E. from the University of Michigan. Before law school, he spent several years as an automotive engineer, during which time he co-invented technology leading to U.S. Patent No. 6,934,140.

Follow @PatentJosh on Twitter.

November 14, 2017

CCIA Submits Letter For The Record To House Judiciary Subcommittee On IP

Yesterday, we submitted a letter for the record to the House Judiciary Committee Subcommittee On Courts, Intellectual Property and the Internet. This letter, written in response to testimony submitt...

November 8, 2017

Misleading Stats Lead To Misleading Testimony In Front Of Congress

Yesterday afternoon, the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, and the Internet held a hearing on “Sovereign Immunity and the Intellectual Property System.” ...

October 31, 2017

CCIA Files Amicus In IPR Constitutionality Case At Supreme Court

CCIA Files Amicus In IPR Constitutionality Case At Supreme Court Yesterday, we filed an amicus brief (along with the Internet Association, the National Association of Realtors, the Software and Infor...

October 30, 2017

New Trial On Design Patent Damages, But A Flawed Test

In the long-running Apple v. Samsung dispute, which has now gone from the trial court to the Federal Circuit to an en banc opinion to the Supreme Court and then back to the Federal Circuit and finally...

October 20, 2017

Tribal Immunity May Not Be Wonder Drug For Allergan

This article was originally published on Law360 and is reprinted here. You’ve probably already heard the story. Allergan PLC owns patents related to relieving dry eyes. These patents allegedly r...

October 18, 2017

Big Tech vs. Big Pharma: An Article Filled With Big Errors

On Monday, the Financial Times published an article by Rana Foroohar. While there are a lot of flaws in the article, one particularly pernicious myth shows up—the myth that patent trolls aren’t ...

October 12, 2017

IPR Successes: The Next Five Years

Over the past month, I’ve shown just how successful the inter partes review (IPR) program has been in its first five years. IPR has saved billions of dollars and helped everyone from city governme...

October 9, 2017

IPR Successes: A Bridge To Sovereign Patent Funds

Patent trolls are a familiar concept at this point, but a “sovereign patent fund” (SPF) might not be. This isn’t the kind of sovereign I wrote about recently in regard to sovereign immunity. �...

October 4, 2017

IPR Successes: Scan-To-Email Defeated By Scanner Makers

In the pantheon of infamous patent trolls, MPHJ is near the top. MPHJ drew attention for their habit of mailing demand letters to anyone they thought might possibly have infringed their scan-to-emai...